HEADER HYDROLASE 28-JAN-98 1A39 TITLE HUMICOLA INSOLENS ENDOCELLULASE EGI S37W, P39W DOUBLE-MUTANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOGLUCANASE I; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CELLULASE, FAMILY 7 ENDOGLUCANASE; COMPND 5 EC: 3.2.1.4; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: PYROGLUTAMATE POST-TRANSLATIONAL MODIFICATION AT COMPND 9 RESIDUE 1 N-LINKED N-ACETYLGLUCOSAMINE ON RESIDUE ASN 247 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMICOLA INSOLENS; SOURCE 3 ORGANISM_TAXID: 34413; SOURCE 4 GENE: POTENTIAL; SOURCE 5 EXPRESSION_SYSTEM: ASPERGILLUS ORYZAE; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 5062; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PHW 697 KEYWDS ENDOGLUCANASE, HYDROLASE, CELLULASE, CELLULOSE DEGRADATION, GLYCOSIDE KEYWDS 2 HYDROLASE FAMILY 7, GLYCOSYLATED PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR G.J.DAVIES,V.DUCROS,R.J.LEWIS,T.V.BORCHERT,M.SCHULEIN REVDAT 6 03-APR-24 1A39 1 HETSYN REVDAT 5 29-JUL-20 1A39 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE REVDAT 4 25-DEC-19 1A39 1 SEQADV SEQRES LINK REVDAT 3 13-JUL-11 1A39 1 VERSN REVDAT 2 24-FEB-09 1A39 1 VERSN REVDAT 1 02-MAR-99 1A39 0 JRNL AUTH G.J.DAVIES,V.DUCROS,R.J.LEWIS,T.V.BORCHERT,M.SCHULEIN JRNL TITL OLIGOSACCHARIDE SPECIFICITY OF A FAMILY 7 ENDOGLUCANASE: JRNL TITL 2 INSERTION OF POTENTIAL SUGAR-BINDING SUBSITES. JRNL REF J.BIOTECHNOL. V. 57 91 1997 JRNL REFN ISSN 0168-1656 JRNL PMID 9335168 JRNL DOI 10.1016/S0168-1656(97)00092-8 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 3 NUMBER OF REFLECTIONS : 18592 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 984 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3138 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 14 REMARK 3 SOLVENT ATOMS : 327 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.011 ; 0.020 REMARK 3 ANGLE DISTANCE (A) : 0.034 ; 0.040 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.038 ; 0.050 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.012 ; 0.050 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.122 ; 0.150 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : 0.179 ; 0.300 REMARK 3 MULTIPLE TORSION (A) : 0.247 ; 0.300 REMARK 3 H-BOND (X...Y) (A) : 0.197 ; 0.300 REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : 4.200 ; 7.000 REMARK 3 STAGGERED (DEGREES) : 17.200; 15.000 REMARK 3 TRANSVERSE (DEGREES) : 23.300; 20.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.400 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.100 ; 3.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.800 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.600 ; 3.000 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1A39 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170337. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : JUL-96 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : LONG FOCUSSING MIRRORS (MSC) REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18592 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : 0.06700 REMARK 200 FOR THE DATA SET : 14.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 51.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.20000 REMARK 200 R SYM FOR SHELL (I) : 0.20000 REMARK 200 FOR SHELL : 4.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NATIVE HUMICOLA INSOLENS ENDOGLUCANASE I REMARK 200 REMARK 200 REMARK: NATIVE COORDINATES NOT YET DEPOSITED REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 8.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.48000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.38500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.70000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.38500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.48000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.70000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PCA A 1 O - C - N ANGL. DEV. = -12.3 DEGREES REMARK 500 LYS A 2 C - N - CA ANGL. DEV. = 21.3 DEGREES REMARK 500 ARG A 17 NE - CZ - NH2 ANGL. DEV. = 3.8 DEGREES REMARK 500 CYS A 18 CA - CB - SG ANGL. DEV. = 6.9 DEGREES REMARK 500 ARG A 21 CD - NE - CZ ANGL. DEV. = 12.1 DEGREES REMARK 500 ARG A 21 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A 94 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 ARG A 103 NE - CZ - NH1 ANGL. DEV. = 4.3 DEGREES REMARK 500 ARG A 108 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG A 117 CD - NE - CZ ANGL. DEV. = 10.2 DEGREES REMARK 500 ARG A 117 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 ARG A 118 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 ASP A 132 CB - CG - OD1 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP A 134 CB - CG - OD1 ANGL. DEV. = 6.5 DEGREES REMARK 500 HIS A 152 N - CA - CB ANGL. DEV. = -12.8 DEGREES REMARK 500 ASP A 173 CB - CG - OD1 ANGL. DEV. = 6.6 DEGREES REMARK 500 TYR A 251 CB - CG - CD2 ANGL. DEV. = -4.5 DEGREES REMARK 500 TYR A 251 CB - CG - CD1 ANGL. DEV. = 3.8 DEGREES REMARK 500 TYR A 252 CB - CG - CD2 ANGL. DEV. = -4.3 DEGREES REMARK 500 ARG A 254 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ALA A 274 CA - C - N ANGL. DEV. = 14.4 DEGREES REMARK 500 ARG A 276 CD - NE - CZ ANGL. DEV. = -8.6 DEGREES REMARK 500 ARG A 277 CA - C - N ANGL. DEV. = 14.1 DEGREES REMARK 500 ARG A 285 NE - CZ - NH2 ANGL. DEV. = -3.9 DEGREES REMARK 500 TYR A 287 CB - CG - CD2 ANGL. DEV. = -3.9 DEGREES REMARK 500 TYR A 287 CB - CG - CD1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ASP A 311 CB - CG - OD1 ANGL. DEV. = 6.8 DEGREES REMARK 500 ARG A 321 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 116 -6.52 80.09 REMARK 500 LYS A 137 33.42 -98.61 REMARK 500 ASN A 275 -168.92 -75.16 REMARK 500 ALA A 328 -164.24 56.23 REMARK 500 ASP A 358 19.74 -141.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLU A 5 10.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: NUC REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CATALYTIC NUCLEOPHILE AS IDENTIFIED BY 2 REMARK 800 -FLUOROCELLOBIOSE LABELING. REMARK 800 REMARK 800 SITE_IDENTIFIER: ACI REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CATALYTIC ACID/BASE. DBREF 1A39 A 2 402 UNP P56680 GUN1_HUMIN 2 402 SEQADV 1A39 TRP A 37 UNP P56680 SER 37 CONFLICT SEQADV 1A39 TRP A 39 UNP P56680 PRO 39 CONFLICT SEQRES 1 A 402 PCA LYS PRO GLY GLU THR LYS GLU VAL HIS PRO GLN LEU SEQRES 2 A 402 THR THR PHE ARG CYS THR LYS ARG GLY GLY CYS LYS PRO SEQRES 3 A 402 ALA THR ASN PHE ILE VAL LEU ASP SER LEU TRP HIS TRP SEQRES 4 A 402 ILE HIS ARG ALA GLU GLY LEU GLY PRO GLY GLY CYS GLY SEQRES 5 A 402 ASP TRP GLY ASN PRO PRO PRO LYS ASP VAL CYS PRO ASP SEQRES 6 A 402 VAL GLU SER CYS ALA LYS ASN CYS ILE MET GLU GLY ILE SEQRES 7 A 402 PRO ASP TYR SER GLN TYR GLY VAL THR THR ASN GLY THR SEQRES 8 A 402 SER LEU ARG LEU GLN HIS ILE LEU PRO ASP GLY ARG VAL SEQRES 9 A 402 PRO SER PRO ARG VAL TYR LEU LEU ASP LYS THR LYS ARG SEQRES 10 A 402 ARG TYR GLU MET LEU HIS LEU THR GLY PHE GLU PHE THR SEQRES 11 A 402 PHE ASP VAL ASP ALA THR LYS LEU PRO CYS GLY MET ASN SEQRES 12 A 402 SER ALA LEU TYR LEU SER GLU MET HIS PRO THR GLY ALA SEQRES 13 A 402 LYS SER LYS TYR ASN PRO GLY GLY ALA TYR TYR GLY THR SEQRES 14 A 402 GLY TYR CYS ASP ALA GLN CYS PHE VAL THR PRO PHE ILE SEQRES 15 A 402 ASN GLY LEU GLY ASN ILE GLU GLY LYS GLY SER CYS CYS SEQRES 16 A 402 ASN GLU MET ASP ILE TRP GLU ALA ASN SER ARG ALA SER SEQRES 17 A 402 HIS VAL ALA PRO HIS THR CYS ASN LYS LYS GLY LEU TYR SEQRES 18 A 402 LEU CYS GLU GLY GLU GLU CYS ALA PHE GLU GLY VAL CYS SEQRES 19 A 402 ASP LYS ASN GLY CYS GLY TRP ASN ASN TYR ARG VAL ASN SEQRES 20 A 402 VAL THR ASP TYR TYR GLY ARG GLY GLU GLU PHE LYS VAL SEQRES 21 A 402 ASN THR LEU LYS PRO PHE THR VAL VAL THR GLN PHE LEU SEQRES 22 A 402 ALA ASN ARG ARG GLY LYS LEU GLU LYS ILE HIS ARG PHE SEQRES 23 A 402 TYR VAL GLN ASP GLY LYS VAL ILE GLU SER PHE TYR THR SEQRES 24 A 402 ASN LYS GLU GLY VAL PRO TYR THR ASN MET ILE ASP ASP SEQRES 25 A 402 GLU PHE CYS GLU ALA THR GLY SER ARG LYS TYR MET GLU SEQRES 26 A 402 LEU GLY ALA THR GLN GLY MET GLY GLU ALA LEU THR ARG SEQRES 27 A 402 GLY MET VAL LEU ALA MET SER ILE TRP TRP ASP GLN GLY SEQRES 28 A 402 GLY ASN MET GLU TRP LEU ASP HIS GLY GLU ALA GLY PRO SEQRES 29 A 402 CYS ALA LYS GLY GLU GLY ALA PRO SER ASN ILE VAL GLN SEQRES 30 A 402 VAL GLU PRO PHE PRO GLU VAL THR TYR THR ASN LEU ARG SEQRES 31 A 402 TRP GLY GLU ILE GLY SER THR TYR GLN GLU LEU GLN MODRES 1A39 ASN A 247 ASN GLYCOSYLATION SITE MODRES 1A39 PCA A 1 GLN PYROGLUTAMIC ACID HET PCA A 1 8 HET NAG A 800 14 HETNAM PCA PYROGLUTAMIC ACID HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 1 PCA C5 H7 N O3 FORMUL 2 NAG C8 H15 N O6 FORMUL 3 HOH *327(H2 O) HELIX 1 1 SER A 35 TRP A 37 5 3 HELIX 2 2 VAL A 66 ASN A 72 1 7 HELIX 3 3 TYR A 81 TYR A 84 5 4 HELIX 4 4 GLY A 164 TYR A 167 5 4 HELIX 5 5 GLY A 225 CYS A 228 5 4 HELIX 6 6 ASN A 243 VAL A 246 5 4 HELIX 7 7 ASP A 312 ALA A 317 1 6 HELIX 8 8 ARG A 321 GLU A 325 1 5 HELIX 9 9 ALA A 328 ARG A 338 1 11 HELIX 10 10 GLU A 355 ASP A 358 1 4 HELIX 11 11 GLY A 360 ALA A 362 5 3 HELIX 12 12 PRO A 372 VAL A 378 1 7 SHEET 1 A11 LYS A 292 ILE A 294 0 SHEET 2 A11 LEU A 280 GLN A 289 -1 N GLN A 289 O LYS A 292 SHEET 3 A11 PHE A 266 ALA A 274 -1 N LEU A 273 O GLU A 281 SHEET 4 A11 GLU A 128 VAL A 133 -1 N VAL A 133 O PHE A 266 SHEET 5 A11 ARG A 390 GLY A 392 -1 N GLY A 392 O GLU A 128 SHEET 6 A11 GLN A 12 THR A 19 1 N PHE A 16 O TRP A 391 SHEET 7 A11 GLY A 23 LEU A 33 -1 N ASN A 29 O LEU A 13 SHEET 8 A11 ARG A 108 LEU A 112 -1 N LEU A 112 O PHE A 30 SHEET 9 A11 VAL A 341 TRP A 347 -1 N MET A 344 O VAL A 109 SHEET 10 A11 ASN A 143 SER A 149 -1 N SER A 149 O VAL A 341 SHEET 11 A11 TRP A 201 ALA A 203 -1 N ALA A 203 O SER A 144 SHEET 1 B 2 ILE A 40 ARG A 42 0 SHEET 2 B 2 CYS A 73 MET A 75 -1 N ILE A 74 O HIS A 41 SHEET 1 C 4 VAL A 86 ASN A 89 0 SHEET 2 C 4 SER A 92 GLN A 96 -1 N ARG A 94 O THR A 87 SHEET 3 C 4 GLU A 383 THR A 387 -1 N TYR A 386 O LEU A 93 SHEET 4 C 4 ASP A 132 ASP A 134 -1 N ASP A 134 O THR A 385 SHEET 1 D 2 GLY A 192 CYS A 194 0 SHEET 2 D 2 TYR A 221 CYS A 223 -1 N CYS A 223 O GLY A 192 SHEET 1 E 3 GLU A 197 ASP A 199 0 SHEET 2 E 3 VAL A 210 HIS A 213 -1 N HIS A 213 O GLU A 197 SHEET 3 E 3 CYS A 239 TRP A 241 -1 N TRP A 241 O VAL A 210 SSBOND 1 CYS A 18 CYS A 24 1555 1555 2.02 SSBOND 2 CYS A 51 CYS A 73 1555 1555 2.03 SSBOND 3 CYS A 63 CYS A 69 1555 1555 2.06 SSBOND 4 CYS A 140 CYS A 365 1555 1555 2.07 SSBOND 5 CYS A 172 CYS A 195 1555 1555 2.04 SSBOND 6 CYS A 176 CYS A 194 1555 1555 2.02 SSBOND 7 CYS A 215 CYS A 234 1555 1555 2.02 SSBOND 8 CYS A 223 CYS A 228 1555 1555 2.05 SSBOND 9 CYS A 239 CYS A 315 1555 1555 2.01 LINK C PCA A 1 N LYS A 2 1555 1555 1.37 LINK ND2 ASN A 247 C1 NAG A 800 1555 1555 1.41 SITE 1 NUC 1 GLU A 197 SITE 1 ACI 1 GLU A 202 CRYST1 50.960 81.400 94.770 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019623 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012285 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010552 0.00000 HETATM 1 N PCA A 1 10.781 -18.130 37.960 1.00 22.75 N HETATM 2 CA PCA A 1 10.006 -18.803 39.007 1.00 23.82 C HETATM 3 CB PCA A 1 9.749 -17.821 40.152 1.00 23.86 C HETATM 4 CG PCA A 1 10.236 -16.462 39.603 1.00 23.16 C HETATM 5 CD PCA A 1 10.884 -16.834 38.240 1.00 23.51 C HETATM 6 OE PCA A 1 11.491 -16.072 37.481 1.00 21.68 O HETATM 7 C PCA A 1 8.687 -19.074 38.274 1.00 25.72 C HETATM 8 O PCA A 1 8.372 -18.549 37.170 1.00 25.27 O